MacroGenics
Tracked across 2 events · 13 articles · First seen May 12, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: MacroGenics, Inc. is selling its GMP manufacturing operations and CDMO business to Bora Pharmaceuticals for US$122.5 million, and will sign a long-term CDMO Service Agreement with Bora Pharmaceuticals.
May 12, 2026 · 6 articles
Business
Impact: MacroGenics sold its GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million and entered into a long-term CDMO Service Agreement, which could provide financial benefits and ensure manufacturing support.
Jul 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Track MacroGenics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard